Equipment and method for in vitro release measurements on topical dosage forms

References

• Franz TJ. Percutaneous absorption. On the relevance of in vitro data. J Invest Dermatol 1975;64:190–195
   PubMed Web of Science ®Google Scholar
• Franz T. The finite dose technique as a valid in vitro model for the study of percutaneous absorption. Curr Probl Dermatol 1978;7:58–68
   PubMedGoogle Scholar
• Farinha A, Toscano C, Campos R, et al. Permeation of naproxen from saturated solutions and commercial formulations through synthetic membranes. Drug Dev Ind Pharm 2003;29:489–494
   PubMed Web of Science ®Google Scholar
• Shah V, Elkins J, Lam S, Skelly J. Determination of in vitro drug release from hydrocortisone creams. Int J Pharm 1989;53:53–59
   Web of Science ®Google Scholar
• Siewert M, Dressman J, Brown C, Shah V. FIP/AAPS guidelines to dissolution/in vitro release testing of novel/special dosage forms. AAPS PharmSciTech 2003;1:4–7
   Google Scholar
• PareraMorell JL, Contreras Claramonte MD, PareraVialard A. Validation of a release diffusion cell for topical dosage forms. Int J Pharm 1996;137:49–55
   Google Scholar
• Scheuplein RJ. Permeability of the skin. In: Lee DHK, Falk HL, Murphy SD, eds. Handbook of physiology. Comprehensive Physiology. New York: Oxford University Press; 2011
   Google Scholar
• Schlumpf M, Schmid P, Durrer S, et al. Endocrine activity and developmental toxicity of cosmetic UV filters – an update. Toxicology 2004;205:113–122
   PubMed Web of Science ®Google Scholar
• Keshary PR, Chien YW. Mechanisms of controlled nitroglycerin administration (I): development of a finite-dosing skin permeation system. Drug Dev Ind Pharm 1984;10:883–913
   Web of Science ®Google Scholar
• Fares HM, Zatz JL. Measurement of drug release from topical gels using two types of apparatus. Pharm Tech 1995;1:52–58
   Google Scholar
• Bharkatiya M, Nema RK, Bhatnagar M. Development and characterization of transdermal patches of metoprolol tartrate. Asian J Pharm Clin Res 2010;3:130–134
   Google Scholar
• Chien YW, Valia KH. Development of a dynamic skin permeation system for long term permeation studies. Drug Dev Ind Pharm 1984;10:575–599
   Web of Science ®Google Scholar
• Martin B, Watts OM, Shoroot B, Jamoulle JC. A new diffusion cell and automated method for measuring the pharmaceutical availability of topical dosage form. Int J Pharm 1989;49:63–68
   Google Scholar
• Friend DR. In vitro skin penetration techniques. Int J Pharm 1993;94:23–30
   Google Scholar
• Bosman IJ, Lawant AL, Avegaart SR, Ensing K. Novel diffusion cell for in vitro transdermal permeation, compatible with automatic dynamic sampling. J Pharm Sci 1992;81:1153–1156
   PubMedGoogle Scholar
• Parera JL, Contreras MD, Vialard A. Validation of a release diffusion cell for topical dosage forms. Int J Pharm 1996;137:49–55
   Google Scholar
• Miron DS, Radulescu FS, Voicu VA, et al. Diffusional and rheological evaluations as valuable quality control and in vivo performance prognostic tools for topical drug products. Farmacia 2010;58:485–493
   Google Scholar
• Shiow-Fern Ng, Rose JJ, Sanderson FD, et al. Validation of a static Franz diffusion cell system for in vitro permeation studies. AAPS PharmSciTech 2010;11:1432–1441
   PubMedGoogle Scholar
• Gonzalez H, Farbrot A, Larkö O, Wennberg AM. Percutaneous absorption of the sunscreen BZ-3 after repeated whole-body applications, with and without ultraviolet irradiation. Br J Dermatol 2006;154:337–340
   PubMed Web of Science ®Google Scholar
• Michaels A, Chandrasekaran SK, Francis W, Meredith M. Drug permeation through human skin: theory and in vitro experimental measurement. AIChE J 1975;21:985–996
   Web of Science ®Google Scholar
• Sato S, Wan Kim S. Macromolecular diffusion through polymer membranes. Int J Pharm 1984;22:229–255
   Web of Science ®Google Scholar
• Cross SE, Innes B, Roberts MS, et al. Human skin penetration of sunscreen nanoparticles: in vitro assessment of a novel micronized zinc oxide formulation. Skin Pharmacol Physiol 2007;20:148–154
   PubMed Web of Science ®Google Scholar
• Mavon A, Miquel C, Lejeune O, et al. In vitro percutaneous absorption and in vivo stratum corneum distribution of an organic and a mineral sunscreen. Skin Pharmacol Physiol 2007;20:10–20
   PubMed Web of Science ®Google Scholar
• Jiang R, Roberts MS, Collins DM, Benson HAE. Absorption of sunscreens across human skin: an evaluation of commercial products for children and adults. J ClinPharmacol 1999;48:635–637
   PubMed Web of Science ®Google Scholar
• Franz TJ, Lehman PA, Franz SF, Guin JD. Comparative percutaneous absorption of lindane and permethrin. Arch Dermatol 1996;132:901–905
   PubMed Web of Science ®Google Scholar
• Chatelain E, Gabard B, Surber C. Skin penetration and sun protection factor of five UV filters: effect of the vehicle. Appl Skin Physiol 2003;16:28–35
   PubMedGoogle Scholar
• Benson HAE, Sarveiya V, Risk S, Roberts SM. Influence of anatomical site and topical formulation on skin penetration of sunscreens. Ther Clin Risk Manag 2005;1:209–218
   PubMedGoogle Scholar
• Okereke CS, Kadry AM, Abdel-Rahman MS, et al. Metabolism of benzophenone-3 in rats. Drug Metab Dispos 1993;21:788–791
   PubMed Web of Science ®Google Scholar
• Felix T, Hall B, Brodbelt JS. Determination of benzophenone-3 and metabolites in water and human urine by solid-phase microextraction and quadrupole ion trap GC-MS. Anal Chim Acta 1998;371:195–203
   Web of Science ®Google Scholar
• Sarveiya V, Risk S, Benson HAE. Liquid chromatographic assay for common sunscreen agents: application to in vivo assessment of skin penetration and systemic absorption in human volunteers. J Chromatogr B Anal Technol Biomed Life Sci 2004;803:225–231
   PubMed Web of Science ®Google Scholar
• Hayden CG, Roberts MS, Benson HA. Systemic absorption of sunscreen after topical application. Lancet 1997;350:863–864
   PubMed Web of Science ®Google Scholar
• Gustavsson-Gonzalez H, Farbrot A, Larkö O. Percutaneous absorption of benzophenone-3, a common component of topical sunscreens. Clin Exp Dermatol 2002;27:691–694
   PubMedGoogle Scholar
• Vidal L, Chisvert A, Canals A, Salvador A. Sensitive determination of free benzophenone-3 in human urine samples based on an ionic liquid as extractant phase in singledropmicroextraction prior to liquid chromatography analysis. J Chromatogr A 2007;1174:95–103
   PubMedGoogle Scholar
• Kurul E, Hekimoglu S. Skin permeation of two different benzophenone derivatives from various vehicles. Int J Cosmetic Sci 2001;23:211–218
   PubMedGoogle Scholar
• Strong M, Johnstone PW. Interventions for treating scabies. Cochrane Database Syst Rev 2007;3:54–58
   Google Scholar
• Currie BJ, McCarthy JS. Permethrin and ivermectin for scabies. N Engl J Med 2010;362:717–725
   PubMed Web of Science ®Google Scholar
• Bachewar NP, Thawani VR, Mali SN, et al. Comparison of safety, efficacy, and cost effectiveness of benzyl benzoate, permethrin, and ivermectin in patients of scabies. Indian J Pharmacol 2009;41:9–14
   PubMed Web of Science ®Google Scholar
• Ishaaya I, Casida JE. Properties and toxicological significance of esterases hydrolyzing permethrin and cypermethrin in trichoplusia ni larval gut and integument. Pesticide Biochem Physiol 1980;14:178–184
   Web of Science ®Google Scholar
• Sanna V, Peana AT, Moretti MDL. Effect of vehicle on diclofenac sodium permeation from new topical formulations: in vitro and in vivo studies. Curr Drug Deliv 2009;6:93–100
   PubMedGoogle Scholar
• Klein K. Encyclopedia of UV absorbers for sunscreen products. Cosmet Toilet 1992;107:45–63
   Google Scholar
• El Dareer SM, Kalin JR, Tillery KF, Hill D. Disposition of 2-hydrox-4-oxybenzophenone in rats dosed orally, intravenously or topically. J Toxicol Environ Health 1986;19:491–502
   PubMed Web of Science ®Google Scholar
• Okereke CS, Abdel-Rahman MS. Species differences in the disposition of benzophenone-3 after oral administration in rat and mouse. Toxic Substances J 1994;13:239–251
   Google Scholar
• Hany J, Nagel R. Nachweis von UV-filtersubstanzen in muttermilch. Deutsche Lebensmittel-Rundschau 1995;91:341–345
   Web of Science ®Google Scholar